Iterative Health
PrivateLast Round
Series C
Apr 30, 2026
Est. Valuation
$1.3B
Total Funding Raised
$270.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Iterative Health operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series C round in April 2026.
Iterative Health is a healthcare technology company that provides an AI-powered platform to accelerate clinical research for life sciences companies and healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Medical Imaging, Computer Vision
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iterative Health Comparables
Compare Iterative Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TriNetX | 76% | |
| Olympus Corporation | 76% | |
| Medtronic | 76% |
For institutional investors. Book with your work email.
Iterative Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 30, 2026 | ||||
| Series B | Jan 19, 2022 | ||||
| Series A | Aug 3, 2021 | ||||
| Seed | Aug 3, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Iterative Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Valor Capital Group | Seed |
| Breyer Capital | Series A, Series B |
| Clearlake Capital Group | Series B |
| Time BioVentures | Seed |
| GV | Series C |
| Plug and Play Tech Center | Series B |
| P5 Health Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 16, 2026
Grew 20% QoQ, from 169 to 203 employees.
- Jul 21, 2026
Job postings indicate presence in Warsaw, Poland and Munich, Germany.
For institutional investors. Book with your work email.
Iterative Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Iterative Health's valuation, stock price, and market status.
Is Iterative Health a public or private company?
Iterative Health is a private company.
What is the current stock price of Iterative Health?
Iterative Health is a private company, so its shares have no public market price. Caplight tracks Iterative Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Iterative Health worth (valuation)?
Iterative Health's valuation is estimated at $1.3B based on funding round data.
Can I buy Iterative Health stock?
Iterative Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Iterative Health's last funding round?
Iterative Health's most recent funding round was Series C on April 30, 2026.
Who are the main investors in Iterative Health?
Key investors in Iterative Health include Clearlake Capital Group, GV, Obvious Ventures, Wavemaker Three-Sixty Health, Intrepid Growth Partners.
Will Iterative Health IPO soon?
No public IPO plans have been announced for Iterative Health.
How can I track Iterative Health secondary market activity?
Caplight tracks bids, offers, and trades in Iterative Health's shares on secondary markets.